Cambridge, United Kingdom

Cornelia Anna Mundt

This inventor holds 1 USPTO granted patent. Top assignee: The Babraham Institute. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Cornelia Anna Mundt. Retrieved from https://idiyas.com/inventor/cornelia-anna-mundt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Cornelia Anna Mundt: Innovator in Immunoglobulin Research

Introduction

Cornelia Anna Mundt is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of immunology, particularly through her innovative research and patents. Her work focuses on the control regions in human immunoglobulins, which are crucial for understanding immune responses.

Latest Patents

Cornelia holds a patent for an invention titled "Immunoglobulin control region." This invention relates to a control region in human immunoglobulins, to parts thereof, and to their use. This patent represents a significant advancement in the understanding and manipulation of immune system components.

Career Highlights

Cornelia is affiliated with the Babraham Institute, where she conducts her research. Her work at this esteemed institution has allowed her to explore various aspects of immunology and contribute to the scientific community.

Collaborations

Cornelia collaborates with Marianne Brueggemann, who is also a prominent figure in the field. Their partnership has led to advancements in immunological research and has fostered a productive exchange of ideas.

Conclusion

Cornelia Anna Mundt's contributions to immunology through her patent and research at the Babraham Institute highlight her role as an innovator in the field. Her work continues to influence the understanding of immune responses and the development of therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…